Sign in

CIK 0001824893

  • Non-accelerated filer
  • Smaller reporting company

Surrozen, Inc./DE

Sign in to watch
Ticker
SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
301374889
Phone
+1 650-475-2820
Business address
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Consonance-HFW Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-10-10 Vanhove Geertrui Chief Medical Officer Grant or award · Option (right to buy) +24,587 24,587
2022-10-10 Vanhove Geertrui Chief Medical Officer Grant or award · Option (right to buy) +1,760 1,760
2022-10-10 Williams Charles O Chief Financial Officer Returned to the company · Option (right to buy) −77,972 0
2022-10-10 Williams Charles O Chief Financial Officer Returned to the company · Option (right to buy) −2,433 0
2022-10-10 Williams Charles O Chief Financial Officer Returned to the company · Option (right to buy) −12,164 0
2022-10-10 Williams Charles O Chief Financial Officer Returned to the company · Option (right to buy) −97,676 0
2022-10-10 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +12,164 12,164
2022-10-10 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +97,676 97,676
2022-10-10 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +2,433 2,433
2022-10-10 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +77,972 77,972
2022-10-10 Yeh Wen-Chen Chief Scientific Officer Returned to the company · Option (right to buy) −29,567 0
2022-10-10 Yeh Wen-Chen Chief Scientific Officer Returned to the company · Option (right to buy) −5,562 0
2022-10-10 Yeh Wen-Chen Chief Scientific Officer Grant or award · Option (right to buy) +5,562 5,562
2022-10-10 Yeh Wen-Chen Chief Scientific Officer Grant or award · Option (right to buy) +29,567 29,567
2022-10-10 Parker Craig C Chief Executive Officer Returned to the company · Option (right to buy) −35,987 0
2022-10-10 Parker Craig C Chief Executive Officer Returned to the company · Option (right to buy) −2,065 0
2022-10-10 Parker Craig C Chief Executive Officer Returned to the company · Option (right to buy) −181,270 0
2022-10-10 Parker Craig C Chief Executive Officer Returned to the company · Option (right to buy) −315,310 0
2022-10-10 Parker Craig C Chief Executive Officer Grant or award · Option (right to buy) +35,987 35,987
2022-10-10 Parker Craig C Chief Executive Officer Grant or award · Option (right to buy) +315,310 315,310

Page 14 of 20 · 398 trades